Breast cancer resistance protein (BCRP), an ATP-dependent efflux transporter, confers drug resistance to many chemotherapy agents. BCRP is over-expressed in tumors exposed to acidic environment; it is therefore important to establish the effect of low pH on BCRP transport activity. Recently, it has been reported that BCRP transports substrates more efficiently in an acidic microenvironment. In the present study, we examine the pH-dependency of BCRP using methothrexate (MTX), pemetrexed (PMX) and estrone sulfate (ES) as model substrates. Our study revealed about 40-fold increase in the BCRP-mediated transport of both PMX and MTX when the pH was decreased from 7.4 to 5.5. In contrast, only a 2-fold increase was observed for estrone sulfate. These results indicate a mechanism of transport that is directly dependent on the effective ionization state of both the substrates and BCRP. For ES, which retains a constant ionization state throughout the applied pH, the observed mild increase in activity is attributable to the overall changes in the effective ionization state and conformation of BCRP. For MTX and PMX, the marked increase in BCRP-transport activity was likely due to the change in ionization state of MTX and PMX at lowered pH and their intermolecular interactions with BCRP. To further rationalize the molecular basis of the pH-dependency, molecular modeling and docking studies were carried out using an homology model of BCRP, which has been closely examined by Mao and coworkers in structural and site-directed mutagenesis studies. Based on docking studies, all model compounds were found to associate with arginine 482 (R482) by direct salt bridge interactions via their negatively charged carboxylate or sulfate groups. However, at lower pH, both protonated MTX and PMX formed an additional salt bridge interaction between their positively charged moieties and the nearby negatively charged aspartic acid 477 (D477) carboxylate side chain. The formation of this "salt bridge triad" is expected to increase the This article has not been copyedited and formatted. The final version may differ from this version. 
Introduction
Multi-drug resistance (MDR) in tumors represents a significant obstacle in chemotherapeutic treatment of cancers. Drug efflux is one major drug resistance mechanism, through which chemotherapeutics is actively removed from tumor cells. Clinically relevant efflux transporters include P-glycoprotein (P-gp), multidrug resistance-related proteins (MRPs) and breast cancer resistance protein (BCRP) (Diestra et al., 2003) . BCRP (ABCG2) is a membrane-bound protein and belongs to the ATP-binding cassette (ABC) family (Doyle et al., 1998; . BCRP is present in many solid tumors and normal tissues including placenta, blood-brain barrier, small intestine, testis, liver, adrenal gland and stem cells (Doyle et al., 1998; Fetsch et al., 2006) . BCRP confers drug resistance to many anti-cancer agents including mitoxantrone, topotecan, irinotecan, tyrosine kinase inhibitors (imatinib, gefitinib and erlotinib), and antifolates (methotrexate, tomudex and GW 1843) (Robey et al., 2001; Volk and Schneider, 2003; Shafran et al., 2005; Bram et al., 2006) . The implication of BCRP with a variety of anticancer agents makes BCRP a clinically relevant target for studying drug resistance mechanisms.
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One of the intriguing characteristics of tumors is the acidic microenvironment (i.e., an extracellular pH as low as 5.8) as compared to normal tissues (Tannock and Rotin, 1989; Ojugo et al., 1999) . The causes for the acidic pH environment in tumors are not well-understood. It has been linked to the increased use of the glycolytic pathways and the compromised vasculature of tumor, which may lead to the poor removal of lactic acid (Vaupel, 2004) . Based on the observation that the activities of many transporters are affected by the environmental pH, it is likely that BCRP acts differently under acidic pH, which further affects its drug resistance profile.
Recently, Breedveld et al. demonstrated that BCRP transports substrates more efficiently under acidic pH using both intact cell based assay and membrane vesicle based assay (Breedveld et al., 2007 ). In the current study, we explored the possible mechanisms for the pH-dependent BCRP transport using methothexate (MTX), pemetrexed (PMX) and estrone sulfate (ES) as model compounds (Figure 1 ). In addition, the molecular basis of the observed pH-dependency was examined using docking studies with the recent inward-facing conformation homology model of BCRP (Rosenberg et al., 2010) .
Materials and Methods

Chemicals
[
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or BCRP-transfected HEK293 cells were cultured in 500 cm 2 plates (Corning 431110). When 75% confluence was reached, the cells were washed twice with PBS and scraped into a residue of PBS. After centrifugation at 1700 rpm at 4°C for 5 min, the cell pellet was diluted with a hypotonic buffer containing 1mM sodium bicarbonate at pH 9 and 1% EDTA free protease inhibitors. The cells were allowed to sit and swell on ice for 5 minutes followed by vigorous shaking 20 times. The resultant cell lysate was centrifuged at 1700 rpm at 4°C for 5 min to remove nuclei, mitochondria and whole cells. The supernatant (crude membrane fraction) was layered over 40% (w/v) sucrose solution and centrifuged at 25000 rpm at 4°C for 30 min. The turbid layer at the interface was collected and suspended in Tris/sucrose buffer (250 mM sucrose containing 50 mM Tris/HCl, pH 7.4), and centrifuged at 25000 rpm for 40 min. The membrane fraction was collected and re-suspended in a small volume (150-250 μ l) of Tris-sucrose buffer.
The membrane vesicles were made by slowly passing the suspension through a 27 gauge needle 20 times. The vesicle containing solution was aliquoted into 100 uL fractions and frozen at -80 ºC. The amount of membrane vesicles was quantified by measuring membrane protein using the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL). Our procedure for the preparation of inverted membrane vesicles is similar to Volk et al., and the percentage of inside-out vesicles was reported to be on average 70% (range 50~96%) (Volk and Schneider, 2003) .
Vesicular uptake study
The vesicular uptake studies were performed using the rapid filtration method according to Pratt and Dantzig with minor modifications (Tabas and Dantzig, 2002; Pratt et al., 2006 
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All molecular modeling studies were carried out using the Schrödinger modeling suite package (Schrodinger). The homology model of BCRP in the inward-facing closed conformation was previously reported (Rosenberg et al., 2010) and was based on the recently solved X-ray structure of mouse p-glycoprotein (PDB 3G5U) (Aller et al., 2009) . This model has been previously shown to be consistent with experimentally observed conformation change upon substrate binding (Rosenberg et al., 2010) and for the identification of important residues for drug transport (Ni et al., 2010) . The homology modeled BCRP structure was refined by restraint energy minimization using the OPLS 2005 forcefield (Jorgensen et al., 1996) with the generalized born solvent accessible (GB/SA) implicit solvent model (Still et al., 1990) .
Docking of all compounds was carried out using Glide at Standard Precision (Friesner et al., 2004) . For each ligand, the top ranked docking geometry based on Gscore scoring function is reported. The electrostatic potential surfaces of MTX and PMX were evaluated based on the protonated and deprotonated forms of both compounds at pH 5.5 and physiological pH. The pK a values of PMX, MTX and ES were calculated by ACD pK a predictor software (Advanced Chemistry Development, Inc., Toronto, Canada;
http://www.acdlabs.com/products/phys_chem_lab/pka/), a reliable knowledge-based pKa calculator using Hammett equations derived from a database of over 30000 experimental pKa values (Balogh et al., 2009 ).
Statistical analysis
Statistical comparisons between the two groups were made using the two-sample t-test.
Differences were considered to be statistically significant when P < 0.05. Multiple groups were compared using ANOVA with Holm-Sidak post-hoc test at P < 0.05 level of significance.
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Results
Effect of pH on ATP-dependent BCRP transport activity of PMX, MTX and ES At pH 7.4, PMX uptake in BCRP membrane vesicles was two-fold higher than that of control vesicles (p< 0.05). In contrast, PMX uptake in BCRP vesicles was about 20-fold higher than that in the control vesicles at pH 5.5 (Figure 2A) . By subtracting the uptake in BCRP vesicles from that in control vesicles, BCRP-mediated transport of PMX increased by 43-fold at pH 5.5 compared to at physiological pH. MTX was used here as a positive control for method validation.
Consistent with previous report (Breedveld et al., 2007) , a marked increase in BCRP transport of MTX was observed when the pH decreased from 7.4 to 5.5 ( Figure 2B ). The observed pHsensitive BCRP-mediated transport may be a consequence of 1) changed intrinsic protein activity at different pH and/or 2) altered ionization state of the substrate molecules and thus different substrate-transporter protein interaction. To elucidate the mechanism of BCRP pH-dependency, we investigated the BCRP-mediated transport of estrone sulfate, a compound with constant ionization status at the applied pH range (Figure 3 ). As the pH decreased from 7.4 to 5.5, we observed a 1.7-fold increase in the BCRP uptake of estrone sulfate, a finding that was quite subtle as compared to the 40-fold increase observed for PMX and MTX. No optimal pH was observed for maximum transport activity for BCRP.
Effect of BCRP inhibitor on PMX and MTX uptake into BCRP expressing and control vesicles at low pH
To confirm the markedly increased PMX and MTX transport at low pH was a BCRP-mediated process, we determined the effect of BCRP-specific inhibitor on the pH-dependent BCRP This article has not been copyedited and formatted. The final version may differ from this version. 
pH-dependent BCRP transport kinetics of PMX
In order to characterize the influence of pH on BCRP mediated transport kinetics of PMX, concentration dependent uptake studies were performed at pH 5.2 and pH 6.5. From the time course of PMX uptake at pH 5.5, a 15 minute time point was within the linear uptake range and was used to determine the concentration-dependent uptake of PMX (data not shown). As shown in Figure 5 , the BCRP-mediate uptake of PMX was saturable and followed Michaelis-Menten kinetics; with K m of 0.39 ± 0.08 mM and V max of 4725 ± 279 pmol/mg/min at pH 5.2 and a K m of 1.47 ± 0.35 mM and V max of 1993 ± 213 pmol/mg/min at pH 6.5.
pK a ' and ionization state of BCRP transport substrates
The pK a 's of PMX, MTX and ES were evaluated and are shown in Figure 6 . The predicted pK a 's of MTX were within 0.5 pK a units of its experimentally determined pK a 's of 3.2, 4.5 and 5.6 (Szakacs and Noszal, 2006). The predicted protonated site for the base was on the N5 atom on PMX and on the N5 atom on MTX. The predicted pKa of ES was 2.0 for the sulfate group.
Based on the predicted pK a 's, it is expected the acidic group of all three model compounds to be permanently charged at the applied experimental pH of 7.4 and 5.5. At the acidic pH of 5.5, however, the basic group of both PMX and MTX were expected to undergo protonation of its pteridine ring.
BCRP R482 binding site
The amino acid residue 482 is a reported hot spot for BCRP substrate specificity and plays a crucial role in the transport of MTX (Honjo et al., 2001; . Studies from our laboratory showed that R482 was also important for the recognition of PMX and estrone sulfate.
To understand molecular basis for the increased binding selectivity of PMX and MTX at low pH, the BCRP binding site consisting of R482 was closely examined for possible key residues that can provide significant interaction with the charged carboxylate and pteridinium groups of PMX and MTX in the recently published homology model.
BCRP is a homodimeric transport membrane protein consisting of an extracellular nucleotide binding (NB) domain and a transmembrane helical (TM) domain in each of its monomeric subunits. The TM domains (Wang et al., 2008) consist of six transmembrane helices with R482 located in the helix III (H3) region along the transport channel of BCRP ( Figure 7A ). In the model, residues D477, R465 and H630 were calculated to be the only ionizable residues within an 18Å radius of R482 located within the transport channel of BCRP that were capable of interacting simultaneously with the charged moiety ( Figure 7C ). The nearest interatomic distance between R482 and R465 guanidinium groups was 6.9Å, which is similar to the interatomic distance of 6.0Å of the carboxylate atoms in the energy minimized conformation of PMX ( Figure 7B ). H630, which was located on the helix VI region further inside along the BCRP transport channel, has a nearest interatomic side-chain distances to R482 and R465 of 6.0Å and 9.5Å, respectively. D477, which was located on the transmembrane helix III region at the interface between the TM and NB domains, has a nearest interatomic side-chain distances to R482 and R465 of 6.9Å and 8.7Å, respectively. The nearest interatomic side-chain distances between the arginines to H630 and D477 were found to be similar to the interatomic distances of 
Role of R482 in pH-dependent BCRP transport
The results from docking studies indicate that the formation of "salt bridge triad" between PMX / MTX molecules and BCRP at amino acid residues R482, R465, and D477 may contribute to the greatly enhanced transport activity of BCRP for PMX and MTX at low pH. To confirm the role of the "salt bridge triad" in the observed pH-dependent BCRP transport, we determined the influence of polymorphic BCRP mutation at 482 on the pH-dependent transport of PMX, MTX and estrone sulfate. As shown in Figure 9A , the extent of pH-dependency, calculated as the ratio of uptake at pH 5.5 over the uptake at pH 7.4, was about 61, 12 and 6 for R482 (wild-type BCRP), R482G (mutant BCRP) and R482T (mutant BCRP), respectively. A similar trend was observed for MTX, i.e., pH-dependent transport was significantly disturbed when positively charged Arginine at 482 (R482) was replaced by non-ionized amino acids (R482G, R482T) at lower pH ( Figure 9B ). In contrast, the transport of estrone sulfate by wild-type and mutant BCRP were similarly enhanced (1.5-fold) when the pH changed from 7.4 to 5.5 (Figure 10 ).
Discussion
It is well known that pH plays an important role in modulating the functional activity of proteins. In the present study, we examined the influence of pH on BCRP transport activity using BCRP substrates PMX and estrone sulfate, and characterized the possible mechanism for the observed pH-dependency. Vesicular uptake assays revealed that BCRP-mediated transport of PMX was 43-fold higher at acidic pH (5.5) when compared to the transport at physiological pH (7.4). In addition, the increased uptake at lower pH associated with an increased affinity of PMX for BCRP (as indicated by decreased K m values), and a markedly increased BCRP transport capacity (V max ). The pH-dependent BCRP transport was also observed for estrone sulfate. However, extent of pH-dependency was mild, with a pH alteration from 7.4 to 5.5 leading to only a 2-fold increase in BCRP-mediated transport of estrone sulfate. This is consistent with observation from Breedveld et al. that BCRP transports substrate drugs more efficiently at low pH (Breedveld et al., 2007) . However, our data further suggests that the extent of pH-dependent transport activity can vary significantly depending on the ionization status of the substrates.
This article has not been copyedited and formatted. The final version may differ from this version. With a pK a of 2, the ionization state of estrone sulfate is constant through the applied pH (pH 7.4 and pH 5.5) (Figure 6) . Therefore, any changes in estrone sulfate uptake from pH 7.4 to pH 5.5
should be a result of the pH-induced conformational and/or ionization changes associated with the transporter protein. The mild pH-effect observed for estrone sulfate indicates that the intrinsic activity of BCRP increased at lower pH, but only to a moderate extent. Conversely, the significant pH-dependent transport observed for MTX and PMX may be mainly due to the change in the ionization state of the substrate and the subsequent interaction with BCRP. PMX is a polyelectrolyte carrying two carboxyl groups, with pK a of 3.46 (α-carboxyl) and 4.77 (γ-carboxyl), and the guanidinic N-1 on the pterine ring (pKa 5.27) (predicted using ACD software) (Figure 6 ). At physiological pH, PMX exists in a predominantly negatively charged form due to the deprotonation of the two carboxyl groups. When the pH decreased from 7.4 to 5.5, there is a negligible change in the ionization of carboxyl groups (i.e., from 99% to 97%), but a marked increase in the calculated ionization of nitrogen group (i.e., from 0% to 30%) in water. It is possible that the enhanced transport of PMX at low pH is due to the increased positive charge in the PMX molecule, which in turn leads to the stronger electrostatic interaction with BCRP.
To understand molecular basis for the increased BCRP transport of PMX and MTX at low pH, molecular modeling and docking studies were carried out. Based on the homology model of BCRP, residues D477, R465 and H630 were identified to be the only ionizable residues within a 18Å radius of R482 located within the transport channel of BCRP. In the presence of two positively charged R482 and R465 residues, the pK a 's of D477 and H630 were expected to be significantly perturbed and will remain predominantly negatively and neutrally charged, 
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Schrodinger Maestro v9.0, Glide v5.5, Prime v2.1, Macromodel v9.7. Schrodinger, LLC: New York. The ionization residues within 18Å of R482 located within the transport channel is shown. Values shown are mean ± S.D. of each experiment (n=4) (* p < 0.05, **, p < 0.01, ***, p < 0.001 compared with the BCRP-mediated uptake at pH 7.4)
